| Tissue response and biodistribution of injectable cellulose nanocrystal composite hydrogels KJ De France, M Badv, J Dorogin, E Siebers, V Panchal, M Babi, ... ACS Biomaterials Science & Engineering 5 (5), 2235-2246, 2019 | 53 | 2019 |
| Nanostructured degradable macroporous hydrogel scaffolds with controllable internal morphologies via reactive electrospinning F Xu, I Gough, J Dorogin, H Sheardown, T Hoare Acta biomaterialia 104, 135-146, 2020 | 40 | 2020 |
| Biomaterials for protein delivery for complex tissue healing responses J Dorogin, JM Townsend, MH Hettiaratchi Biomaterials Science 9 (7), 2339-2361, 2021 | 13 | 2021 |
| Moderate‐Affinity Affibodies Modulate the Delivery and Bioactivity of Bone Morphogenetic Protein‐2 J Dorogin, HB Hochstatter, SO Shepherd, JE Svendsen, MA Benz, ... Advanced Healthcare Materials 12 (26), 2300793, 2023 | 1 | 2023 |
| Injectable and Dynamically‐Crosslinked Zwitterionic Hydrogels for Anti‐Fouling and Tissue Regeneration Applications Z Pan, J Dorogin, A Lofts, G Randhawa, F Xu, R Slick, M Abraha, C Tran, ... Advanced Healthcare Materials, 2304397, 2024 | | 2024 |
| An Expanded Palette of Fluorescent COS/H2S‐Releasing Donors for H2S Delivery, Detection, and In Vivo Application KG Fosnacht, J Dorogin, PM Jefferis, MH Hettiaratchi, MD Pluth Angewandte Chemie International Edition, e202402353, 2024 | | 2024 |
| Stimulus activated cork-shell capsules T Hoare, J Dorogin, D Koff, A Singh US Patent 11,883,540, 2024 | | 2024 |
| Hydrogels containing affibodies and uses thereof M Hettiaratchi, J Dorogin, H Hochstatter, V Spaulding, A Galindo, C Asnes, ... US Patent App. 18/340,754, 2024 | | 2024 |
| Statistical optimization of hydrazone-crosslinked hyaluronic acid hydrogels for protein delivery EA Mozipo, AN Galindo, JD Khachatourian, CG Harris, J Dorogin, ... Journal of Materials Chemistry B 12 (10), 2523-2536, 2024 | | 2024 |
| Drug-Loaded Core-Shell Microcapsules with Solid and Porous Silica Corks for Ultrasound-Triggered Drug Delivery K Baker, A Delfino, A Singh, J Dorogin, T Hoare 2023 AIChE Annual Meeting, 2023 | | 2023 |
| Moderate‐Affinity Affibodies Modulate the Delivery and Bioactivity of Bone Morphogenetic Protein‐2 (Adv. Healthcare Mater. 26/2023) J Dorogin, HB Hochstatter, SO Shepherd, JE Svendsen, MA Benz, ... Advanced Healthcare Materials 12 (26), 2370164, 2023 | | 2023 |
| Moderate-affinity Affibodies For Tunable Co-delivery Of Immunomodulatory And Osteogenic Proteins J Dorogin, MA Benz, KM Fear, MJ Martin, P Hosseinzadeh, ... TISSUE ENGINEERING PART A 29 (9-10), 2023 | | 2023 |
| Affinity-based Biomaterials For Angiogenic Protein Delivery HB Hochstatter, JR O'Hara-Smith, CL Asnes, J Dorogin, SC Oh, ... TISSUE ENGINEERING PART A 28, 372-373, 2022 | | 2022 |
| Moderate-affinity Affibodies Control The Release And Bioactivity Of Bone Morphogenetic Protein-2 J Dorogin, VR Spaulding, KM Fear, HB Hochstatter, P Hosseinzzadeh, ... TISSUE ENGINEERING PART A 28, 345-346, 2022 | | 2022 |
| In situ gelling zwitterionic hydrogel compositions, and methods of use thereof T Hoare, J Dorogin, PAN Zhicheng, NIP Rivera | | 2021 |
| FABRICATION OF CORK-SHELL MICROCAPSULES FOR BIOMEDICAL APPLICATIONS WITH FOCUS ON ULTRASOUND TRIGGERED RELEASE J Dorogin | | 2019 |
| Evaluating the biological response and biodistribution of cellulose nanocrystal nanocomposite hydrogels K De France, M Badv, J Dorogin, E Cranston, T Hoare ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018 | | 2018 |
Todd HoareDepartment of Chemical Engineering, McMaster UniversityПодтвержден адрес электронной почты в домене mcmaster.ca
